Rohan Garje, MD, chief of genitourinary oncology at the Miami Cancer Institute.
Garje Assesses Sarcomatoid vs Classic Urothelial Carcinoma
Rohan Garje, MD, explains some of the differences between the sarcomatoid and classic carcinoma of the bladder.
Chemotherapy With Surgery Betters Survival in Sarcomatoid Urothelial Carcinoma
Rohan Garje, MD, discusses the goals of his research in assessing the outcomes of sarcomatoid vs classic urothelial carcinoma of bladder.
Kidney Cancer Awareness Month: Assessing Best Treatment Options in RCC
In an interview with Targeted Oncology™, Rohan Garje, MD, discussed available therapies, how to assess risks, and manage toxicities for patients with renal cell carcinoma.
2 Commerce Drive Cranbury, NJ 08512